Cargando…

Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients

We tested the hypothesis that circulating tumor cells (CTCs) in preoperative peripheral blood (PPB) and intraoperative pulmonary venous blood (IPVB) could predict poor long-term survival in resected non-small cell lung cancer (NSCLC) patients. CTCs were separated from blood using magnetic beads coat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yunsong, Cheng, Xu, Chen, Zhong, Liu, Yi, Liu, Zhidong, Xu, Shaofa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503943/ https://www.ncbi.nlm.nih.gov/pubmed/28694485 http://dx.doi.org/10.1038/s41598-017-05154-x

Ejemplares similares

Sleeve lobectomy by video-assisted thoracic surgery versus thoracotomy for non-small cell lung cancer
por: Zhou, Shijie, et al.
Publicado: (2015)

Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study
por: Duan, Xinchun, et al.
Publicado: (2018)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Prognostic Role of Circulating Tumor Cells in the Pulmonary Vein, Peripheral Blood, and Bone Marrow in Resectable Non-Small Cell Lung Cancer
por: Lee, Jeong Moon, et al.
Publicado: (2022)

Combination of CT and telomerase(+) circulating tumor cells improves diagnosis of small pulmonary nodules
por: Zhang, Wen, et al.
Publicado: (2021)

PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2019)

Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancer
por: LI, JIE, et al.
Publicado: (2015)

Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2022)

Circulating tumor cells in the central and peripheral venous compartment – assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma
por: Fang, Zhu-Ting, et al.
Publicado: (2014)

Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer
por: Berg, Janna, et al.
Publicado: (2022)

Elevated Pulmonary Artery Systolic Pressure is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer
por: Yang, Xue, et al.
Publicado: (2020)

Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients
por: Lv, Yongbin, et al.
Publicado: (2017)

Correlation of pulmonary venous circulating tumor cells with clinicopathological parameters in patients with early-stage lung adenocarcinoma
por: Xu, Shi-Bin, et al.
Publicado: (2019)

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer
por: Peeters, D J E, et al.
Publicado: (2011)

Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2015)

Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer
por: Berg, Janna, et al.
Publicado: (2022)

Correction: Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2017)

Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer
por: Yu, Lian, et al.
Publicado: (2021)

Subsegmentectomy versus segmentectomy resection for the treatment of operable patients with stage IA non-small cell lung cancer: A meta-analysis
por: Song, Liwei, et al.
Publicado: (2023)

No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression
por: Förnvik, Daniel, et al.
Publicado: (2013)

Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung
por: Yang, Zhi, et al.
Publicado: (2016)

Peripheral Blood Transcripts Predict Preoperative Obstructive Total Anomalous Pulmonary Venous Connection
por: Wan, Zunmin, et al.
Publicado: (2022)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

Preclinical study of peripheral parenchymal lymphatic drainage in lung
por: Zhou, Shijie, et al.
Publicado: (2022)

A validated nomogram integrating baseline peripheral T-lymphocyte subsets and NK cells for predicting survival in stage I–IIIA non-small cell lung cancer after resection
por: Xu, Lili, et al.
Publicado: (2022)

Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes
por: Gardner, Kirby P., et al.
Publicado: (2021)

Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
por: Zhang, Qi, et al.
Publicado: (2019)

Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Cheng, Xu, et al.
Publicado: (2021)

Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer
por: Wang, Ying, et al.
Publicado: (2023)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Small cell ovarian carcinoma: Long term survival in juvenile case with poor prognostic features
por: Stewart, Lauren, et al.
Publicado: (2016)

Arterial or Venous: Where Are the Circulating Tumor Cells?
por: Gray, Elin S.
Publicado: (2015)

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
por: Zeng, Jing, et al.
Publicado: (2014)

Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood
por: Goto, Taichiro, et al.
Publicado: (2017)

Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer
por: Dong, Jingsi, et al.
Publicado: (2019)

SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer
por: Wu, Dong-ming, et al.
Publicado: (2017)

Higher Lung and Heart Doses Decrease Early and Long-Term Survival, Respectively, in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation
por: Ma, Zeliang, et al.
Publicado: (2023)

Association of Increased Circulating Acetic Acid With Poor Survival in Pseudomonas aeruginosa Ventilator-Associated Pneumonia Patients
por: Qi, Xiaoling, et al.
Publicado: (2021)

Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer
por: Ning, J., et al.
Publicado: (2012)

Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer
por: Messaritakis, Ippokratis, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kt1vnpjhd58a3k73d60u3gndht